Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: CuttingEdge Bio who wrote (3113)	10/2/2020 4:42:48 PM
From: Biotechwantabe	Read Replies (1) \| Respond to of 3557

With the spread increasing, it would be nice to slow it down before before vaccinations Start. But supply won’t last long. Better to use it than do nothing but hope. I would hope this puts an end to protests and Live political events. Maybe better to mail in the votes.

To: CuttingEdge Bio who wrote (3113)	10/17/2020 10:11:22 AM
From: Biotechwantabe	Read Replies (1) \| Respond to of 3557

Us cases >50k/dy 1.5m/month Production estimated Regeneron 300k/m Roche 1m prophylaxis Not enough supply to make a dent. To expensive to produce. Leave to vaccines except special small outbreaks- old age home.... Hospitalized Still waiting for data. But if it works the probably be used to save lives. Out of hospital If distributed to all would consume full supply If distributed to seronegative (old and comorbidity 20%) Then you might have enough supply. Anyway, other companies will need to deliver vaccines and antibodies to make up for supply shortage. Just not sure why government hasn’t stepped up to fund project to increase supply 10X. Just in case the other companies fail.